Skip to Main Content

Paper Details

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.
J Antimicrob Chemother
32
2012

Datasets

Release 1.2